Go to the profile of novaGo

novaGo

CEO, NovaGo

About novaGo

NovaGo Therapeutics is a Swiss biotech startup company dedicated to the development of human antibody therapeutics that promote nerve repair and regeneration in brain and retina. NovaGo is pursuing the development of its lead molecule, NG004, in two indications, regenerative therapy for ischemic stroke and novel therapy for diabetic retinopathy.

Therapeutic Areas

Ophthalmics

Technologies

Regenerative medicine Antibodies

Company Type

Biotechnology – Therapeutics Pharmaceutical

State of Ownership

Private

Sponsorship Group

Networker

Influencer Of

Topics

Editions participated in:

June 2020